The acquisition of sperm is primarily governed by the in the United States under 21 CFR Part 1271. These regulations focus on the prevention of communicable disease transmission.

The commercialization of gametes raises significant ethical questions regarding the rights of the resulting children and the commodification of genetics.

There is a global shift toward "identity-release" models, as many argue that children have a fundamental right to know their biological origins.

The high cost of procurement (often ranging from $800 to $1,500 per vial) creates barriers to entry for lower-income individuals and couples. 4. Conclusion